Answers are grounded in this paper and cite their sources.
The combination of MUC16, TSPAN1, and epithelial cell adhesion molecule (EpCAM) antibodies will likely increase the efficiency of capturing circulating tumor cell in blood of pancreatic ductal adenocarcinoma. To further develop a protocol for isolation of circulating tumor cell in blood of PC patients, high amounts of antibodies (5-10 mg) against EpCAM, MUC16, and TSPAN1 will be needed.
No takes yet. Share an insight, caveat, or question.
Mayado et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: